Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Abstract Background Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (DAMP) protein and reflects mainly neutrophil activation. Serum calprotectin levels might be a good alternative to acute-phase protein as a biomarker in inflammatory rheumatic diseases. The aim...

Full description

Bibliographic Details
Main Authors: Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mahler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen, on behalf of the physicians of the Swiss Clinical Quality Management (SCQM) registry
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Arthritis Research & Therapy
Subjects:
Serum calprotectin
S100A8/S100A9
Biomarker
Rheumatoid arthritis
Psoriatic arthritis
Axial spondyloarthritis
Online Access:http://link.springer.com/article/10.1186/s13075-020-02190-3

Internet

http://link.springer.com/article/10.1186/s13075-020-02190-3

Similar Items